Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer.
ACS Omega. 2023 Mar 16;8(12):10851-10862. doi: 10.1021/acsomega.2c07052. eCollection 2023 Mar 28.
ACS Omega. 2023.
PMID: 37008098
Free PMC article.
Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis.
Lu Y, Pan W, Deng S, Dou Q, Wang X, An Q, Wang X, Ji H, Hei Y, Chen Y, Yang J, Zhang HM.
Lu Y, et al. Among authors: dou q.
Pharmaceuticals (Basel). 2023 Mar 30;16(4):510. doi: 10.3390/ph16040510.
Pharmaceuticals (Basel). 2023.
PMID: 37111268
Free PMC article.
Review.
Item in Clipboard
A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy.
Wang XX, Wu LH, Ji H, Liu QQ, Deng SZ, Dou QY, Ai L, Pan W, Zhang HM.
Wang XX, et al.
Front Mol Biosci. 2022 Sep 29;9:1001788. doi: 10.3389/fmolb.2022.1001788. eCollection 2022.
Front Mol Biosci. 2022.
PMID: 36250008
Free PMC article.
Item in Clipboard
Treatment-Related Coronary Disorders of Fluoropyrimidine Administration: A Systematic Review and Meta-Analysis.
Lu Y, Deng S, Dou Q, Pan W, Liu Q, Ji H, Wang X, Zhang HM.
Lu Y, et al. Among authors: dou q.
Front Pharmacol. 2022 May 13;13:885699. doi: 10.3389/fphar.2022.885699. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35645806
Free PMC article.
Item in Clipboard
Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response.
Wang XX, Wu LH, Dou QY, Ai L, Lu Y, Deng SZ, Liu QQ, Ji H, Zhang HM.
Wang XX, et al.
Front Mol Biosci. 2022 Oct 21;9:1034928. doi: 10.3389/fmolb.2022.1034928. eCollection 2022.
Front Mol Biosci. 2022.
PMID: 36339715
Free PMC article.
Item in Clipboard
The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma.
Liu QQ, Wang XX, Ji H, Dou QY, Zhang HM.
Liu QQ, et al.
Med Oncol. 2024 Mar 25;41(5):91. doi: 10.1007/s12032-024-02309-5.
Med Oncol. 2024.
PMID: 38526607
Item in Clipboard
Cite
Cite